Imaging Diagnostic Systems, Inc. (IDSI) is a medical technology company located in Fort Lauderdale, Florida, engaged primarily in the research, development, and marketing of a non-invasive breast imaging system.
IDSI is a pioneer in the field of medical optical imaging and has made major strides in the detection of breast abnormalities. Since the Company's inception in early 1994, IDSI has developed a innovative breast imaging device, named Computed Tomography Laser Breast Imaging (CTLM®) that utilizes state-of-the-art laser technology and proprietary algorithms to create three dimensional cross sectional images of the breast without the use of x-rays and compression.
Recognizing that a non-invasive painless breast imaging system would be a benefit to the consumer and the medical industry, IDSI placed its primary focus in an area of a enormous concern: breast cancer. With over 1.3 million biopsies preformed each year and 80% of those resulting in negative findings, a need for a breast imaging system that was not limited by age, density, or size was evident.
Imaging Diagnostic Systems, Inc. has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO 13485 certification, China SFDA and FDA export certification, enabling sales in international markets.
IDSI's stock is traded on the Over the Counter Bulletin Board (OTC: BB) under the ticker symbol IMDS.